Digital Health Startups

A biotech company offering gene expression analysis tools for blood-based biomarker detection across multiple cancer types. The company develops molecular signatures and liquid biopsy solutions for biopharma, diagnostics, and CRO partners.

1 investor

Genedrive Diagnostics develops and commercialises a rapid point-of-care pharmacogenetic testing platform that detects genetic variants to guide personalised medicine decisions in emergency healthcare. The UK-based company's tests help clinicians tailor drug choices based on a patient's genetics.

1 investor

GeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.

1 investor

GeneralPractice.AI is a platform for primary care clinicians that generates personalized prevention and lifestyle medicine plans during routine consultations. It helps GPs deliver structured, evidence-based management plans for chronic disease prevention and health optimization without adding administrative burden.

1 investor

Generate Life Sciences was a reproductive, newborn stem cell, and genetic services company offering products and services to help families grow and protect their families. It has been acquired by CooperSurgical.

1 investor

GeneTech provides non-invasive prenatal testing (NIPT) using fetal cell-free DNA from maternal blood, along with clinical laboratory testing services, offered to certified medical institutions in Japan. It introduced NIPT in Japan in 2013 and runs a domestic analysis lab, serving pregnant patients and their families through partner hospitals.

1 investor

Genetica offers genetic testing services designed for people of Asian descent, analyzing DNA to provide personalized insights on health risks, nutrition, physical traits, and development potential. It serves individuals and parents seeking to optimize lifestyle, disease prevention, and children's education and development plans.

1 investor

Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.

1 investor

Geneyx offers a genomic data analysis platform for secondary and tertiary interpretation of NGS data, including exome, whole genome sequencing, and gene panels, with AI/ML-driven variant interpretation, automated annotation, and customizable reporting. It serves genetics labs, life-science companies, clinical researchers, and research institutes worldwide, integrating with LIMS and existing bioinformatic pipelines.

1 investor

GenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.

1 investor

GenieBiome (G-NiiB) develops microbiome-modifying technology and therapeutic candidates supported by clinical trials, using next-generation sequencing. The company focuses on treating human diseases through microbiome-based solutions.

1 investor

GeniusVets provides a marketing program for veterinary practices, including websites, search engine marketing, content, and a directory that helps pet owners find local vets. It serves veterinarians and veterinary clinics in the animal health industry.

1 investor

GenMD creates digital twins of healthcare datasets, allowing health systems to support research, AI development, and external partnerships while preserving patient privacy. It serves healthcare providers with privacy-preserving synthetic data for the health data and AI category.

1 investor

Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.

1 investor

Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.

1 investor

Genome Medical provides telehealth-enabled genetic counseling, testing, and clinical trial access for patients with rare diseases. The company partners with hospitals, health systems, and life sciences organizations to deliver expert genetic services at scale.

1 investor

GenoME develops liquid biopsy tests using DNA methylation biomarkers for early disease detection and monitoring, particularly in cancer diagnostics. The company's pipeline identifies novel biomarkers and delivers rapid, cost-effective PCR tests for applications including companion diagnostics and disease monitoring.

1 investor

GenomicMD provides clinical-grade genomic risk assessments to physicians for integrating personalized medicine into patient care, using polygenic analysis to identify disease risk and guide preventive health management. The company serves medical practices and patients seeking evidence-based genetic screening beyond traditional family history assessments.

1 investor

Genomics is a genetics company that uses polygenic risk scores and DNA analysis to predict an individual's risk of common diseases, offering risk assessment tools through a single at-home test. It serves insurance and other partners, employers, life sciences and pharmaceutical companies, and healthcare systems for disease prediction, drug discovery, and precision health.

1 investor

GenMedPro is a genetics-based medication management platform that analyzes 26 genes to identify drug-drug and gene-drug interactions across a patient's entire medication regimen. The platform serves healthcare providers and care teams to reduce prescribing errors, prevent adverse events, and optimize medication safety for complex polypharmacy cases.

1 investor

GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.

1 investor

GenomSys develops modular software for storing, processing and sharing genomic data based on the ISO/IEC 23092 MPEG-G standard, serving diagnostic laboratories, hospitals, research centers and biotech companies. The company operates in computational genomics and precision medicine, with a Swiss parent company and an Italian subsidiary running its MPEG-G Competence Center in Milan.

1 investor

Genotix Bio develops the DaVinci, a compact nanoarray analyzer that detects proteins and nucleic acids at single-molecule resolution for research applications. The instrument enables ultrasensitive biomarker detection with minimal sample volumes and fast processing times.

1 investor

Genpulse builds AI infrastructure and purpose-built devices that capture health data and process it in real time to deliver insights to users and practitioners. It offers medical-grade AI diagnostic devices (for hair/scalp, skin, dental, eye, and gynecological analysis), white-label deployment, and APIs, SDKs, and medical AI datasets for building healthcare applications.

1 investor